The G-250A polymorphism in the hepatic lipase gene promoter is associated with changes in hepatic lipase activity and LDL cholesterol: The KANWU Study

Nutr Metab Cardiovasc Dis. 2008 Feb;18(2):88-95. doi: 10.1016/j.numecd.2006.09.008. Epub 2007 Feb 26.

Abstract

Background and aims: Hepatic lipase (HL) catalyzes the hydrolysis of triglycerides and phospholipids from lipoproteins, and promotes the hepatic uptake of lipoproteins. A common G-250A polymorphism in the promoter of the hepatic lipase gene (LIPC) has been described. The aim was to study the effects of the G-250A polymorphism on HL activity, serum lipid profile and insulin sensitivity.

Methods and results: Altogether 151 healthy subjects (age 49+/-8 years, BMI 26.5+/-3.0kg/m(2)) were randomly assigned for 3 months to an isoenergetic diet containing either a high proportion of saturated fatty acids (SFA diet) or monounsaturated fatty acids (MUFA diet). Within groups there was a second random assignment to supplements with fish oil (3.6g n-3 FA/day) or placebo. At baseline, the A-250A genotype was associated with high serum LDL cholesterol concentration (P=0.030 among three genotypes). On the MUFA diet carriers of the A-250A genotype presented a greater decrease in LDL cholesterol concentration than subjects with other genotypes (P=0.007 among three genotypes). The rare -250A allele was related to low HL activity (P<0.001 among three genotypes). The diet did not affect the levels of HL activity among the genotypes.

Conclusion: The A-250A genotype of the LIPC gene was associated with high LDL cholesterol concentration, but the MUFA-enriched diet reduced serum LDL cholesterol concentration especially in subjects with the A-250A genotype.

Publication types

  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Australia
  • Blood Glucose / drug effects
  • Cholesterol, LDL / blood*
  • Dietary Fats / administration & dosage*
  • Europe
  • Fatty Acids / administration & dosage
  • Fatty Acids, Monounsaturated / administration & dosage
  • Female
  • Fish Oils / administration & dosage
  • Gene Expression Regulation, Enzymologic / drug effects
  • Gene Frequency
  • Genetic Predisposition to Disease
  • Humans
  • Hypercholesterolemia / genetics
  • Hypercholesterolemia / metabolism
  • Hypercholesterolemia / prevention & control*
  • Insulin / blood
  • Insulin Resistance / genetics*
  • Lipase / genetics
  • Lipase / metabolism*
  • Liver / drug effects*
  • Liver / enzymology
  • Male
  • Middle Aged
  • Phenotype
  • Polymorphism, Single Nucleotide*
  • Postprandial Period
  • Promoter Regions, Genetic*
  • Time Factors

Substances

  • Blood Glucose
  • Cholesterol, LDL
  • Dietary Fats
  • Fatty Acids
  • Fatty Acids, Monounsaturated
  • Fish Oils
  • Insulin
  • LIPC protein, human
  • Lipase